Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sun Product Research Heats Up; U.K. Agency Warns About Unapproved OTC

This article was originally published in The Tan Sheet

Executive Summary

As pharmaceutical firms work on injectable products that in the future could compete with sunscreens and suntan oils and lotions, health authorities in the U.K. warn that an unapproved drug marketed as "injectable tan" is being sold over the counter there
Advertisement

Related Content

Regulatory News In Brief: Dakota Lab shutters, FDA warns on web links and supplement GMPs, melanotan caution in U.K.
Regulatory News In Brief: Dakota Lab shutters, FDA warns on web links and supplement GMPs, melanotan caution in U.K.
Injectable tan crackdown

Topics

Advertisement
UsernamePublicRestriction

Register

PS102394

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel